Persistence with VKA treatment in newly treated atrial fibrillation patients: an analysis based on a large sample of 38,076 German patients.

about

Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset.

P2860

Q54975650-28B6EE57-2E44-4807-AB58-1984CC69FFED

P2860

Persistence with VKA treatment in newly treated atrial fibrillation patients: an analysis based on a large sample of 38,076 German patients.

Item

http://www.wikidata.org/entity/Q47675427

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Persistence with VKA treatment ...... ple of 38,076 German patients.

@en

Persistence with VKA treatment ...... ple of 38,076 German patients.

@nl

type

Item

label

Persistence with VKA treatment ...... ple of 38,076 German patients.

@en

Persistence with VKA treatment ...... ple of 38,076 German patients.

@nl

prefLabel

Persistence with VKA treatment ...... ple of 38,076 German patients.

@en

Persistence with VKA treatment ...... ple of 38,076 German patients.

@nl

P1476

Persistence with VKA treatment ...... ple of 38,076 German patients.

@en

P2093

Andreas Fuchs

http://www.w3.org/2001/XMLSchema#string

Antje Groth

http://www.w3.org/2001/XMLSchema#string

Matthias Pfannkuche

http://www.w3.org/2001/XMLSchema#string

Thomas Wilke

http://www.w3.org/2001/XMLSchema#string

Ulf Maywald

http://www.w3.org/2001/XMLSchema#string

P2860

A meta-analysis of the association between adherence to drug therapy and mortality

Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)

Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded.

Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.

Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom.

Warfarin discontinuation after starting warfarin for atrial fibrillation.

P2888

s00228-017-2307-2

P304

1437-1447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-017-2307-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28780697

http://www.w3.org/2001/XMLSchema#string

Persistence with VKA treatment in newly treated atrial fibrillation patients: an analysis based on a large sample of 38,076 German patients.

about

P2860

P2860

Persistence with VKA treatment in newly treated atrial fibrillation patients: an analysis based on a large sample of 38,076 German patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698